Technical Analysis for PRTG - Portage Biotech Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | N/A | N/A | Up |
Historical PRTG trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Multiple of Ten Bearish | Other | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Fell Below 20 DMA | Bearish | 0.00% | |
Multiple of Ten Bearish | Other | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Crossed Above 20 DMA | Bullish | -6.17% | |
Multiple of Ten Bullish | Other | -6.17% | |
Outside Day | Range Expansion | -6.17% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
Trending on StockTwits | 1 day ago |
Down 2 % | 2 days ago |
Down 1% | 2 days ago |
Up 2% | 2 days ago |
Up 1% | 2 days ago |
Get this analysis on your stocks daily!
- Earnings date: ???
Portage Biotech Inc. Description
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a small molecule that binds to the stimulator of interferon genes in cancer; CellPorter, a cell permeable peptide platform technology derived from human proteins; PPL-003, an ophthalmic solution; and SBI-101, a blood-conditioning technology to restore balance to the immune system after acute vital organ injury, such as acute kidney injury. It also focuses on nanolipogel technology for use in immune-oncology; and antibodies against a novel T-cell for use as a monotherapy and combination therapy for solid and haematological malignancies. In addition, the company develops antibodies implicated in the inflammatory tumor and tumor-infiltrating immune cell microenvironments; and FOXO4-P53 modulator and C-RAF inhibitor. Portage Biotech Inc. is based in Tortola, British Virgin Islands.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Immunology Solid Tumors Immune System Antibodies Interferon Biotechnology Products Acute Kidney Injury
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 37.5 |
52 Week Low | 27.0775 |
Average Volume | 13,195 |
200-Day Moving Average | 0.00 |
50-Day Moving Average | 0.00 |
20-Day Moving Average | 31.10 |
10-Day Moving Average | 29.14 |
Average True Range | 2.73 |
ADX | 19.29 |
+DI | 17.93 |
-DI | 18.49 |
Chandelier Exit (Long, 3 ATRs ) | 27.82 |
Chandelier Exit (Short, 3 ATRs ) | 35.25 |
Upper Bollinger Band | 35.83 |
Lower Bollinger Band | 26.37 |
Percent B (%b) | 0.36 |
BandWidth | 30.40 |
MACD Line | -1.18 |
MACD Signal Line | -1.20 |
MACD Histogram | 0.0141 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 32.00 | ||||
Resistance 3 (R3) | 32.03 | 31.31 | 31.64 | ||
Resistance 2 (R2) | 31.31 | 30.75 | 31.30 | 31.51 | |
Resistance 1 (R1) | 30.56 | 30.40 | 30.20 | 30.53 | 31.39 |
Pivot Point | 29.84 | 29.84 | 29.66 | 29.83 | 29.84 |
Support 1 (S1) | 29.09 | 29.28 | 28.73 | 29.07 | 28.21 |
Support 2 (S2) | 28.37 | 28.93 | 28.36 | 28.09 | |
Support 3 (S3) | 27.62 | 28.37 | 27.96 | ||
Support 4 (S4) | 27.60 |